Share Email Print

Proceedings Paper

Transperineal laser ablation treatment of benign prostatic obstruction: preliminary results of a pilot study (Conference Presentation)
Author(s): Rob van Kollenburg; Luigi van Riel; Jorg Oddens; Theo de Reijke; Harrie Beerlage; Martijn de Bruin

Paper Abstract

Transperineal laser ablation (TPLA) is a novel minimal invasive treatment of benign prostatic obstruction. TPLA can be performed in an outpatient day-care setting under local anesthesia with optional conscious sedation. The mechanism is bases on thermoablation resulting in coagulative necrosis, which is induced by the laser light of 1064nm. Laser light is delivered in the prostate trough transperineal placed needles. This study aims to treat 20 men by TPLA to evaluate safety and feasibility, and voiding outcomes. TPLA has the potential to become an alternative for standard treatments with urethral approach that require general or spinal anesthesia and hospital admittance.

Paper Details

Date Published: 6 March 2020
Proc. SPIE 11212, Therapeutics and Diagnostics in Urology 2020, 1121203 (6 March 2020); doi: 10.1117/12.2545579
Show Author Affiliations
Rob van Kollenburg, Amsterdam Univ. Medical Ctr. (Netherlands)
Luigi van Riel, Amsterdam Univ. Medical Ctr. (Netherlands)
Jorg Oddens, Amsterdam Univ. Medical Ctr. (Netherlands)
Theo de Reijke, Amsterdam Univ. Medical Ctr. (Netherlands)
Harrie Beerlage, Amsterdam Univ. Medical Ctr. (Netherlands)
Martijn de Bruin, Amsterdam Univ. Medical Ctr. (Netherlands)

Published in SPIE Proceedings Vol. 11212:
Therapeutics and Diagnostics in Urology 2020
Hyun Wook Kang, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?